
An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Warren, Richard B, Mrowietz, Ulrich, von Kiedrowski, Ralph, Niesmann, Johannes, Wilsmann-Theis, Dagmar, Ghoreschi, Kamran, Zschocke, Ina, Falk, Thomas M, Blödorn-Schlicht, Norbert, Reich, KristianVolume:
389
Langue:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(16)32127-4
Date:
February, 2017
Fichier:
PDF, 345 KB
english, 2017